restart focu
balanc tone optim humil note compani well-posit
emerg pandem stronger also acknowledg
uncertainti crisi need studi potenti long-term effect
could aggreg demand suppli health care management describ
pandem three phase respons restart recoveri compani still
respons phase also work physician local govern offici
ensur smooth restart baselin management expect restart phase begin
back half mid-may plan recoveri throughout summer
april trend april inpati admiss run prior year
level er visit inpati surgeri hospital-bas
outpati surgeri includ mani elect procedur prior year level
importantli management comment volum declin stabil past
week provid use context oper floor especi sinc april like
worst perform month final management note care
patient far context confirm case
reiter ow follow first quarter result revis ebitda estim
mn mn larg reflect conserv view
recoveri phase back-half year also tweak ebitda estim
lower mn mn howev greater visibl
path recoveri bn addit stimulu fund negoti hospit
latest stimulu packag approv senat phase increas
price target base ev/ebitda multipl prior
revis estim figur color annual assumpt
impact recoveri normal oper trend
reiter ow rate also believ potenti payor mix chang less
commercial/mor exchang medicaid relat unemploy manag
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
idc link barclay live interact chart
overweight largest for-profit
hospit system unit state compani
expos local market high weight averag
popul growth maintain high share within
market provid strong negoti leverag
payer hca acceler capit spend plan
continu drive increment growth
next year
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
ebitda upsid capit deploy greater
anticip organ growth acceler
volum weaker anticip ebitda
snapshot trend
incom statement revenu emerg y/i net y/i oper revenu wage oper earn incom incom attribut nci pre-tax tax tax rate excl incom share ep barclay healthcar inc
initi guidancev bpsrev/ bpsopex bpscash bp barclay healthcar inc
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
